Panzara Michael A. 4
4 · LeonaBio, Inc. · Filed Jun 24, 2026
Research Summary
AI-generated summary of this filing
LeonaBio (LONA) Director Michael Panzara Receives 28,000-Share Option Award
What Happened
Michael A. Panzara, a director of LeonaBio, was granted a derivative award on June 23, 2026 covering 28,000 shares. The Form 4 reports the grant as an acquisition (code A) with a reported price of $0.00 per share (this reflects an equity award/option, not an open-market purchase or cash sale).
Key Details
- Transaction date: 2026-06-23; Form 4 filed: 2026-06-24 (timely filing).
- Award: 28,000 shares (derivative/option); reported price $0.00 per share.
- Vesting: The option vests on the earlier of (i) June 23, 2027, or (ii) the day before the issuer’s next annual meeting of stockholders after June 22, 2026 (see footnote F1).
- Grant type: Issued pursuant to the Issuer’s Outside Director Compensation Policy.
- Shares owned after transaction: Not specified in the filing.
Context
This was an equity award (option/derivative) granted as director compensation, not a purchase or sale. The option has a time-based vesting condition; it was not exercised or sold at the time of the filing. Such grants are common for outside directors and are routine compensation disclosures rather than direct market sentiment signals.
Insider Transaction Report
- Award
Stock Option (Right to Buy)
[F1]2026-06-23+28,000→ 28,000 totalExercise: $8.35Exp: 2036-06-22→ Common Stock (28,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest on the earlier of (i) June 23, 2027, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after June 22, 2026. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy.